BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 17267619)

  • 21. Two types of sporadic multiple colorectal cancers with and without HNPCC-like genetic instability.
    Komura K; Masuda H; Esumi M
    Hepatogastroenterology; 1999; 46(30):3115-20. PubMed ID: 10626171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Germline, somatic and epigenetic events underlying mismatch repair deficiency in colorectal and HNPCC-related cancers.
    Yuen ST; Chan TL; Ho JW; Chan AS; Chung LP; Lam PW; Tse CW; Wyllie AH; Leung SY
    Oncogene; 2002 Oct; 21(49):7585-92. PubMed ID: 12386821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of occult high graded microsatellite instabilities in MMR gene mutation negative HNPCC tumors by addition of complementary marker analysis.
    Schiemann U; Müller-Koch Y; Gross M; Glas J; Baretton G; Muders M; Mussack T; Holinski-Feder E
    Eur J Med Res; 2005 Jan; 10(1):23-8. PubMed ID: 15737950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA copy number profiling in microsatellite-stable and microsatellite-unstable hereditary non-polyposis colorectal cancers by targeted CNV array.
    Chen W; Ding J; Jiang L; Liu Z; Zhou X; Shi D
    Funct Integr Genomics; 2017 Jan; 17(1):85-96. PubMed ID: 27896456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methylation tolerance due to an O6-methylguanine DNA methyltransferase (MGMT) field defect in the colonic mucosa: an initiating step in the development of mismatch repair-deficient colorectal cancers.
    Svrcek M; Buhard O; Colas C; Coulet F; Dumont S; Massaoudi I; Lamri A; Hamelin R; Cosnes J; Oliveira C; Seruca R; Gaub MP; Legrain M; Collura A; Lascols O; Tiret E; Fléjou JF; Duval A
    Gut; 2010 Nov; 59(11):1516-26. PubMed ID: 20947886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HNPCC and sporadic MSI-H colorectal cancer: a review of the morphological similarities and differences.
    Jass JR
    Fam Cancer; 2004; 3(2):93-100. PubMed ID: 15340259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic testing for hereditary nonpolyposis colorectal cancer.
    Hoedema R; Monroe T; Bos C; Palmer S; Kim D; Marvin M; Luchtefeld M
    Am Surg; 2003 May; 69(5):387-91; discussion 391-2. PubMed ID: 12769209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. hMLH1 and hMSH2 mutations in families with familial clustering of gastric cancer and hereditary non-polyposis colorectal cancer.
    Kim JC; Kim HC; Roh SA; Koo KH; Lee DH; Yu CS; Lee JH; Kim TW; Lee HL; Beck NE; Bodmer WF
    Cancer Detect Prev; 2001; 25(6):503-10. PubMed ID: 12132870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MSI in endometrial carcinoma: absence of MLH1 promoter methylation is associated with increased familial risk for cancers.
    Whelan AJ; Babb S; Mutch DG; Rader J; Herzog TJ; Todd C; Ivanovich JL; Goodfellow PJ
    Int J Cancer; 2002 Jun; 99(5):697-704. PubMed ID: 12115503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.
    Bonis PA; Trikalinos TA; Chung M; Chew P; Ip S; DeVine DA; Lau J
    Evid Rep Technol Assess (Full Rep); 2007 May; (150):1-180. PubMed ID: 17764220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and molecular characteristics of hereditary non-polyposis colorectal cancer families in Southeast Asia.
    Lee SC; Guo JY; Lim R; Soo R; Koay E; Salto-Tellez M; Leong A; Goh BC
    Clin Genet; 2005 Aug; 68(2):137-45. PubMed ID: 15996210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of a mismatch repair gene defect by microsatellite instability and immunohistochemical analysis in endometrial tumours from HNPCC patients.
    de Leeuw WJ; Dierssen J; Vasen HF; Wijnen JT; Kenter GG; Meijers-Heijboer H; Brocker-Vriends A; Stormorken A; Moller P; Menko F; Cornelisse CJ; Morreau H
    J Pathol; 2000 Nov; 192(3):328-35. PubMed ID: 11054716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PTEN mutational spectra, expression levels, and subcellular localization in microsatellite stable and unstable colorectal cancers.
    Zhou XP; Loukola A; Salovaara R; Nystrom-Lahti M; Peltomäki P; de la Chapelle A; Aaltonen LA; Eng C
    Am J Pathol; 2002 Aug; 161(2):439-47. PubMed ID: 12163369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microsatellite instability and the role of hMSH2 in sporadic colorectalcancer.
    Bubb VJ; Curtis LJ; Cunningham C; Dunlop MG; Carothers AD; Morris RG; White S; Bird CC; Wyllie AH
    Oncogene; 1996 Jun; 12(12):2641-9. PubMed ID: 8700523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular genetic analysis of 103 sporadic colorectal tumours in Czech patients.
    Vasovcak P; Pavlikova K; Sedlacek Z; Skapa P; Kouda M; Hoch J; Krepelova A
    PLoS One; 2011; 6(8):e24114. PubMed ID: 21901162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Methylation of hMLH1 gene promoter in gastric carcinoma with microsatellite instability].
    Li JH; Shi XZ; Liu M; Wang Y; Yu ZH; Xu GW; Lu S
    Ai Zheng; 2005 Mar; 24(3):273-7. PubMed ID: 15757526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic and epigenetic modification of MLH1 accounts for a major share of microsatellite-unstable colorectal cancers.
    Kuismanen SA; Holmberg MT; Salovaara R; de la Chapelle A; Peltomäki P
    Am J Pathol; 2000 May; 156(5):1773-9. PubMed ID: 10793088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased risk for hereditary nonpolyposis colorectal cancer-associated synchronous and metachronous malignancies in patients with microsatellite instability-positive endometrial carcinoma lacking MLH1 promoter methylation.
    Buttin BM; Powell MA; Mutch DG; Rader JS; Herzog TJ; Gibb RK; Huettner P; Edmonston TB; Goodfellow PJ
    Clin Cancer Res; 2004 Jan; 10(2):481-90. PubMed ID: 14760069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic analysis of microsatellite markers in patients from hereditary nonpolyposis colorectal cancer (HNPCC) families.
    Smolarz B; Romanowicz-Makowska H; Langner E; Kozlowska E; Kulig A; Dziki A
    Exp Oncol; 2004 Sep; 26(3):205-9. PubMed ID: 15494688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing.
    Domingo E; Laiho P; Ollikainen M; Pinto M; Wang L; French AJ; Westra J; Frebourg T; Espín E; Armengol M; Hamelin R; Yamamoto H; Hofstra RM; Seruca R; Lindblom A; Peltomäki P; Thibodeau SN; Aaltonen LA; Schwartz S
    J Med Genet; 2004 Sep; 41(9):664-8. PubMed ID: 15342696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.